申请人:Takasugi Hisashi
公开号:US20050038035A1
公开(公告)日:2005-02-17
The present invention relates to a compound of the formula (I) wherein R
1
is optionally substituted aryl; R
2
is optionally substituted aryl, optionally substituted heteroaryl, optionally substituted lower cycloalkyl, optionally substituted aryloxy, optionally substituted arylsulfonyl, vinyl, carbamoyl, protected carboxy or protected amino; ring A is bivalent residue derived from optionally substituted aryl or optionally substituted heteroaryl; X is bivalent residue derived from the group consisting of cycloalkene, naphthalene, unsaturated 5 or 6-membered heteromonocyclic group, each of which is optionally substituted, and substituted benzene; Y is -(A
1
)
m1
-(A
2
)
m2
-; and Z is direct bond or piperazine, or a salt thereof. The compound of the present invention and a salt thereof inhibit apolipoprotein B (Apo B) secretion and are useful as a medicament for prophylactic and treatment of diseases or conditions resulting from elevated circulating levels of Apo B.
本发明涉及一种化合物,其分子式为(I),其中R1为可选取代芳基;R2为可选取代芳基、可选取代杂环芳基、可选取代较低环烷基、可选取代芳氧基、可选取代芳基磺酰基、乙烯基、氨基甲酰基、保护羧基或保护氨基;环A为由可选取代芳基或可选取代杂环芳基衍生的二价残基;X为由环烷烯、萘、不饱和的5或6元杂单环基衍生的二价残基,每种残基均可选取代,以及取代苯基;Y为-(A1)m1-(A2)m2-;Z为直接键或哌嗪,或其盐。本发明的化合物及其盐能抑制载脂蛋白B(Apo B)的分泌,并可用作预防和治疗由于高循环Apo B水平引起的疾病或病症的药物。